Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why is warfarin underutilized in patients with atrial fibrillation?

× No keyword cloud information.

34 in total

Review 1. Antithrombotic therapy in atrial fibrillation.

Authors: G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal: Chest Date: 2001-01 Impact factor: 9.410

2. Systemic embolism in mitral valve disease.

Authors: N Coulshed; E J Epstein; C S McKendrick; R W Galloway; E Walker
Journal: Br Heart J Date: 1970-01

3. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation.

Authors: B F Gage; M Boechler; A L Doggette; G Fortune; G C Flaker; M W Rich; M J Radford
Journal: Stroke Date: 2000-04 Impact factor: 7.914

4. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors: V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal: J Am Coll Cardiol Date: 2001-10 Impact factor: 24.094

5. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Authors: G W Albers; J M Yim; K M Belew; N Bittar; C R Hattemer; B G Phillips; S Kemp; E A Hall; D J Morton; P H Vlasses
Journal: Arch Intern Med Date: 1996-11-11

6. Cerebral embolism and mitral stenosis: survival with and without anticoagulants.

Authors: G F Adams; J D Merrett; W M Hutchinson; A M Pollock
Journal: J Neurol Neurosurg Psychiatry Date: 1974-04 Impact factor: 10.154

7. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors: E Chiquette; M G Amato; H I Bussey
Journal: Arch Intern Med Date: 1998 Aug 10-24

8. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Authors: P A Wolf; T R Dawber; H E Thomas; W B Kannel
Journal: Neurology Date: 1978-10 Impact factor: 9.910

9. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.

Authors: D C McCrory; D B Matchar; G Samsa; L L Sanders; E L Pritchett
Journal: Arch Intern Med Date: 1995-02-13

10. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors:
Journal: Arch Intern Med Date: 1996-02-26

2 in total

1. Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

Authors: Drew R Jones; So-Young Kim; Michael Guderyon; Chul-Ho Yun; Jeffery H Moran; Grover P Miller
Journal: Chem Res Toxicol Date: 2010-05-17 Impact factor: 3.739

2. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice.

Authors: Doreen McBride; Bernd Brüggenjürgen; Stephanie Roll; Stefan N Willich
Journal: J Thromb Thrombolysis Date: 2007-01-27 Impact factor: 5.221

2 in total